FDAnews
www.fdanews.com/articles/122058-biovex-tops-off-70-million-venture-round

BioVex Tops Off $70 Million Venture Round

November 10, 2009
BioVex Inc., a developer of potential cancer-fighting technologies, has added $30 million in venture capital.
Boston Business Journal